CD44 and cancer: In this study comparing manual pathologist and computer-automated assessments of CD44, CD24, and ALDH1A1 expression in 399 cores from 81 cancer-free women with benign breast biopsies, we found wide variation in expression of all three markers in both stroma and epithelium in normal tissue cores and benign lesions.